118 related articles for article (PubMed ID: 32002826)
61. 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.
Hodgetts KJ; Kieltyka A; Brodbeck R; Tran JN; Wasley JW; Thurkauf A
Bioorg Med Chem; 2001 Dec; 9(12):3207-13. PubMed ID: 11711296
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
[TBL] [Abstract][Full Text] [Related]
63. Binding properties of dipropyltryptamine at the human 5-HT1a receptor.
Thiagaraj HV; Russo EB; Burnett A; Goldstein E; Thompson CM; Parker KK
Pharmacology; 2005 Jul; 74(4):193-9. PubMed ID: 15886504
[TBL] [Abstract][Full Text] [Related]
64. Modulation of selective serotonin reuptake inhibitor and 5-HT1A antagonist activity in 8-aza-bicyclo[3.2.1]octane derivatives of 2,3-dihydro-1,4-benzodioxane.
Gilbert AM; Stack GP; Nilakantan R; Kodah J; Tran M; Scerni R; Shi X; Smith DL; Andree TH
Bioorg Med Chem Lett; 2004 Jan; 14(2):515-8. PubMed ID: 14698193
[TBL] [Abstract][Full Text] [Related]
65. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
[TBL] [Abstract][Full Text] [Related]
66. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
[TBL] [Abstract][Full Text] [Related]
67. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
Maciejewska D; Zołek T; Herold F
J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
[TBL] [Abstract][Full Text] [Related]
68. Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.
Ward SE; Eddershaw PJ; Scott CM; Gordon LJ; Lovell PJ; Moore SH; Smith PW; Starr KR; Thewlis KM; Watson JM
J Med Chem; 2008 May; 51(10):2887-90. PubMed ID: 18433113
[TBL] [Abstract][Full Text] [Related]
69. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Cozzi NV; Daley PF
Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
[TBL] [Abstract][Full Text] [Related]
70. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
Picard M; Morisset S; Cloix JF; Bizot JC; Guerin M; Beneteau V; Guillaumet G; Hevor TK
Neuroscience; 2010 Sep; 169(3):1337-46. PubMed ID: 20580787
[TBL] [Abstract][Full Text] [Related]
71. Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.
Grychowska K; Masurier N; Verdié P; Satała G; Bojarski AJ; Martinez J; Pawłowski M; Subra G; Zajdel P
Chem Biol Drug Des; 2015 Oct; 86(4):697-703. PubMed ID: 25684690
[TBL] [Abstract][Full Text] [Related]
72. Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.
Peltonen JM; Nyrönen T; Wurster S; Pihlavisto M; Hoffrén AM; Marjamäki A; Xhaard H; Kanerva L; Savola JM; Johnson MS; Scheinin M
Br J Pharmacol; 2003 Sep; 140(2):347-58. PubMed ID: 12970108
[TBL] [Abstract][Full Text] [Related]
73. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889
[TBL] [Abstract][Full Text] [Related]
74. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands.
De Los Angeles JE; Nikulin VI; Shams G; Konkar AA; Mehta R; Feller DR; Miller DD
J Med Chem; 1996 Sep; 39(19):3701-11. PubMed ID: 8809159
[TBL] [Abstract][Full Text] [Related]
75. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
76. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
[TBL] [Abstract][Full Text] [Related]
77. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
[TBL] [Abstract][Full Text] [Related]
78. Identification of drugs subtype-selective for alpha 2A-, alpha 2B-, and alpha 2C-adrenoceptors in the pig cerebellum and kidney cortex.
Wikberg-Matsson A; Wikberg JE; Uhlén S
Eur J Pharmacol; 1995 Sep; 284(3):271-9. PubMed ID: 8666009
[TBL] [Abstract][Full Text] [Related]
79. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
Valhondo M; Marco I; Martín-Fontecha M; Vázquez-Villa H; Ramos JA; Berkels R; Lauterbach T; Benhamú B; López-Rodríguez ML
J Med Chem; 2013 Oct; 56(20):7851-61. PubMed ID: 24050112
[TBL] [Abstract][Full Text] [Related]
80. Functional characterization of 5-HT
Gadgaard C; Jensen AA
Biochem Pharmacol; 2020 May; 175():113870. PubMed ID: 32088264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
